Featured Research

from universities, journals, and other organizations

Recently-Discovered Protein Could Be Key To Understanding And Preventing Type-2 Diabetes, Yale Researchers Find

Date:
June 6, 2001
Source:
Yale University
Summary:
A protein called Akt2 or Protein Kinase B plays an important role in maintaining glucose balance, possibly leading to a drug target for preventing Type-2 diabetes, Yale researchers report in a study published in the June 1 issue of Science.

New Haven, Conn. -- A protein called Akt2 or Protein Kinase B plays an important role in maintaining glucose balance, possibly leading to a drug target for preventing Type-2 diabetes, Yale researchers report in a study published in the June 1 issue of Science.

Related Articles


"When we inactivated the Akt2 protein in study mice, we found that these mice had defects in insulin's action in liver and skeletal muscle, suggesting that Akt2 plays an important role in insulin signaling and action," said Jason Kim, an author on the study and a research scientist in the Department of Internal Medicine at Yale School of Medicine.

"We also found that this defect in liver and skeletal muscle insulin action altered whole body glucose homeostasis, suggesting that Akt2 might have a role in the development of diabetes," Kim added.

Type 2 diabetes is the most common metabolic disease in the world, affecting 120 million people. Insulin resistance plays a primary role in the development of the disease. Kim said diabetes research is now focused on understanding how insulin acts in the body, especially in the area of the insulin signaling pathway. Insulin acts by binding to a receptor that activates a cascade of proteins that are both known and unknown, causing the cells to increase glucose use. The role of the Akt2 protein had been uncertain until co-authors at the University of Pennsylvania provided lab-generated mice with inactivation of the Akt2 protein.

"These mice develop diabetes in a pattern similar to human diabetes and future studies will examine whether a mutation in the Akt2 protein is also seen in people with diabetes," said Kim who is also an associate at the Howard Hughes Medical Institute and a co-director of NIH-Yale Mouse Metabolic Phenotyping Center. "A defect in this protein in humans can explain how diabetes develops."

Other authors on the study included Gerald I. Shulman, M.D. of Yale; Han Cho, Joanne L. Thorvaldsen, Qingwei Chu, E. Bryan Crenshaw III, Klaus H. Kaestner and Morris J. Birnbaum of the University of Pennsylvania; and Marisa S. Bartolomei of the Howard Hughes Medical Institute and the University of Pennsylvania.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Recently-Discovered Protein Could Be Key To Understanding And Preventing Type-2 Diabetes, Yale Researchers Find." ScienceDaily. ScienceDaily, 6 June 2001. <www.sciencedaily.com/releases/2001/06/010605073031.htm>.
Yale University. (2001, June 6). Recently-Discovered Protein Could Be Key To Understanding And Preventing Type-2 Diabetes, Yale Researchers Find. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2001/06/010605073031.htm
Yale University. "Recently-Discovered Protein Could Be Key To Understanding And Preventing Type-2 Diabetes, Yale Researchers Find." ScienceDaily. www.sciencedaily.com/releases/2001/06/010605073031.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Breakfast Debate: To Eat Or Not To Eat?

Breakfast Debate: To Eat Or Not To Eat?

Newsy (Oct. 23, 2014) Conflicting studies published in the same week re-ignited the debate over whether we should be eating breakfast. Video provided by Newsy
Powered by NewsLook.com
Ebola Fears Keep Guinea Hospitals Empty

Ebola Fears Keep Guinea Hospitals Empty

AP (Oct. 23, 2014) Fears of Ebola are keeping doctors and patients alike away from hospitals in the West African nation of Guinea. (Oct. 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins